The in vivo performance of bioartificial pancreas in bone marrow cavity: A case report of a spontaneous diabetic feline

Biochemical and Biophysical Research Communications

Volumn 393, Issue 3, 2010, Pages 362-364

  Yang, Kai Chiang ^a,b   Wu, Chang Chin ^b,c   Lin, Sheng Chuan ^d   Sumi, Shoichiro ^a   Lin, Feng Huei ^b,e  

^a KYOTO UNIVERSITY   (Japan)

^b School of Electrical and Computer Engineering   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

^d NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Bioartificial pancreas; Bone marrow cavity; Spontaneous diabetes; Xenotransplantation

Indexed keywords

C PEPTIDE; CALCIUM PHOSPHATE; CEMENT; GLUCOSE; ISOPHANE INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL PANCREAS; BIOARTIFICIAL ORGAN; BONE MARROW; CELL ENCAPSULATION; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; EXPERIMENTAL CAT; FEMUR; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VIVO STUDY; INSULINOMA; MALE; MOUSE; NONHUMAN; PERIOPERATIVE PERIOD; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; TUMOR CELL; XENOTRANSPLANTATION;

ANIMALS; BLOOD GLUCOSE; BONE MARROW; C-PEPTIDE; CATS; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HYPERGLYCEMIA; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; PANCREAS, ARTIFICIAL;

ANIMALIA; FELIDAE;

EID: 77949264254     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.152     Document Type: Article

References (19)

1. Kobayashi N. Bioartificial pancreas for the treatment of diabetes. Cell Transplant. 17 (2008) 11-17
2. Fort A., Fort N., Ricordi C., and Stabler C.L. Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas. Cell Transplant. 7 (2008) 997-1003
3. de Groot M., Schuurs T.A., and van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121 (2004) 141-150
4. Carlsson P.O., Palm F., Andersson A., and Liss P. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50 (2001) 489-495
5. Salazar-Bañuelos A., Wright J., Sigalet D., and Benítez-Bribiesca L. The bone marrow as a potential receptor site for pancreatic islet grafts. Arch. Med. Res. 39 (2008) 139-144
6. K.C. Yang, C.C. Wu, S.C. Lin, S. Sumi, F.H. Lin, Intramedullary cavity as an implant site for bioartificial pancreas: an in vivo study on diabetic canine, Transplantation, accepted for publication, doi:10.1097/TP.0b013e3181ca64d1.
7. de Groot M., Schuurs T.A., Keizer P.P., Fekken S., Leuvenink H.G., and van Schilfgaarde R. Response of encapsulated rat pancreatic islets to hypoxia. Cell Transplant. 12 (2003) 867-875
8. Anderson J.M., Rodriguez A., and Chang D.T. Foreign body reaction to biomaterial. Semin. Immunol. 20 (2008) 86-100
9. Yang K.C., Yang C.Y., Wu C.C., Kuo T.F., and Lin F.H. In vitro study of using calcium phosphate cement as immunoisolative device to enclose insulinoma/agarose microspheres as bioartificial pancreas. Biotechnol. Bioeng. 98 (2007) 1288-1295
10. 4. J. Biomed. Mater. Res. 51 (2000) 157-163
11. K.C. Yang, C.C. Wu, S. Sumi, C.L. Theng, Y.H. Wu, T.F. Kuo, F.H. Lin, Calcium phosphate cement chamber as an immunoisolative device for bioartificial pancreas: in vitro and preliminary in vivo study, Pancreas, accepted for publication, doi:10.1097/MPA.0b013e3181be2f95.
12. Kizilel S., Garfinkel M., and Opara E. The bioartificial pancreas: progress and challenges. Diabetes Technol. Ther. 7 (2005) 968-985
13. Takada J., Machado M.A., Peres S.B., Brito L.C., Borges-Silva C.N., Costa C.E., Fonseca-Alaniz M.H., Andreotti S., and Lima F.B. Neonatal streptozotocin-induced diabetes mellitus: a model of insulin resistance associated with loss of adipose mass. Metabolism 56 (2007) 977-984
14. Sweet I.R., Yanay O., Waldron L., Gilbert M., Fuller J.M., Tupling T., Lernmark A., and Osborne W.R. Treatment of diabetic rats with encapsulated islets. J. Cell. Mol. Med. 12 (2008) 2644-2650
15. Wennberg L., Sundberg B., Ekdahl-Nilsson K., and Korsgren O. C-peptide determinations in islet xenotransplantation: a study in the pig-to-mouse model. Cell Transplant. 10 (2001) 165-173
16. Montgomery T.M., Nelson R.W., Feldman E.C., Robertson K., and Polonsky K.S. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism. J. Vet. Intern. Med. 10 (1997) 116-122
17. Bavamian S., Klee P., Britan A., Populaire C., Caille D., Cancela J., Charollais A., and Meda P. Islet-cell-to-cell communication as basis for normal insulin secretion. Diabetes Obes. Metab. S2 (2007) 118-132
18. Yamaoka T. Regeneration therapy of pancreatic beta cells: towards a cure for diabetes?. Biochem. Biophys. Res. Commun. 296 (2002) 1039-1043
19. Palmer J.P., Fleming G.A., Greenbaum C.J., Herold K.C., Jansa L.D., Kolb H., Lachin J.M., Polonsky K.S., Pozzilli P., Skyler J.S., and Steffes M.W. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop. Diabetes 53 (2004) 250-264